Preclinical combination therapy with gemcitabine and mechanisms of resistance

被引:0
|
作者
Peters, GJ [1 ]
vanHaperen, VWTR [1 ]
Bergman, AM [1 ]
Veerman, G [1 ]
SmitskampWilms, E [1 ]
vanMoorsel, CJA [1 ]
Kuiper, CM [1 ]
Braakhuis, BJM [1 ]
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT OTOLARYNGOL,NL-1007 MB AMSTERDAM,NETHERLANDS
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:16 / 24
页数:9
相关论文
共 50 条
  • [41] Resistance mechanisms in photodynamic therapy
    Kristian Berg
    Photochemical & Photobiological Sciences, 2015, 14 : 1376 - 1377
  • [42] Mechanisms of buffer therapy resistance
    Bailey, Kate M.
    Wojtkowiak, Jonathan W.
    Cornnell, Heather H.
    Ribeiro, Maria C.
    Balagurunathan, Yoganand
    Hashim, Arig Ibrahim
    Gillies, Robert J.
    NEOPLASIA, 2014, 16 (04): : 354 - +
  • [43] Mechanisms of Resistance to Photodynamic Therapy
    Casas, A.
    Di Venosa, G.
    Hasan, T.
    Batlle, Al.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (16) : 2486 - 2515
  • [44] Resistance mechanisms in photodynamic therapy
    Berg, Kristian
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2015, 14 (08) : 1376 - 1377
  • [45] Mechanisms of resistance to antiangiogenesis therapy
    Azam, Faisal
    Mehta, Shaveta
    Harris, Adrian L.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (08) : 1323 - 1332
  • [46] Elucidating the mechanisms of colistin resistance and the efficacy of combination therapy in MDR/XDR/PDR Acinetobacter baumannii
    Abou Fayad, A.
    Ghani, D. Abdul
    Bazzi, W.
    Araj, G.
    Matar, G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 116 - 116
  • [47] Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies
    Zou, Yixin
    Yaguchi, Tomonori
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (03) : 264 - 275
  • [48] Benefit of combination therapy in epilepsy: A review of the preclinical evidence with levetiracetam
    Kaminski, Rafal M.
    Matagne, Alain
    Patsalos, Philip N.
    Klitgaard, Henrik
    EPILEPSIA, 2009, 50 (03) : 387 - 397
  • [49] Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer
    Su, C.
    Bond, C.
    Fennell, L.
    Kerr, G.
    Jarde, T.
    Micati, D.
    Engel, R.
    Chan, W. H.
    Hlavca, S.
    Archer, S.
    Mcmurrick, P.
    Hammerlindl, H.
    Lim, F.
    Salik, B.
    Mckeone, D.
    Hartel, G.
    Leggett, B.
    Schaider, H.
    Abud, H.
    Boyle, G.
    Burge, M.
    Whitehall, V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 19 - 20
  • [50] Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism
    Shao, Yu
    Hernandez-Buquer, Selene
    Childress, Paul
    Stayrook, Keith R.
    Alvarez, Marta B.
    Davis, Hannah
    Plotkin, Lilian I.
    He, Yongzheng
    Condon, Keith W.
    Burr, David B.
    Warden, Stuart J.
    Robling, Alexander G.
    Yang, Feng-Chun
    Wek, Ronald C.
    Allen, Matthew R.
    Bidwell, Joseph P.
    ENDOCRINOLOGY, 2017, 158 (09) : 2722 - 2740